Biological Assembly 1  

Global Symmetry: Asymmetric - C1 
Global Stoichiometry: Hetero 2-mer - A1B1 

Biological assembly 1 assigned by authors and generated by PISA (software)

Macromolecule Content

• Total Structure Weight: 30.57 kDa 
• Atom Count: 2,149 
• Modelled Residue Count: 243 
• Deposited Residue Count: 261 
• Unique protein chains: 2

 6Q2X

TEAD4 (216-434) COMPLEXED WITH YAP PEPTIDE (60-100) AND MYRISTOATE (COVALENTLY BOUND) AT 2.1A (P41212 CRYSTAL FORM)

• PDB DOI: 10.2210/pdb6Q2X/pdb

• Classification: TRANSCRIPTION
• Organism(s): Homo sapiens
• Expression System: Escherichia coli BL21
• Mutation(s): No 


• Deposited: 2018-12-03 Released: 2019-07-03 
• Deposition Author(s): Kallen, J.

---

Experimental Data Snapshot

• Method: X-RAY DIFFRACTION
• Resolution: 2.10 Å
• R-Value Free: 0.253 
• R-Value Work: 0.232 
• R-Value Observed: 0.233 

Literature

Structure-based design of potent linear peptide inhibitors of the YAP-TEAD protein-protein interaction derived from the YAP omega-loop sequence.

Furet, P., Salem, B., Mesrouze, Y., Schmelzle, T., Lewis, I., Kallen, J., Chene, P.

(2019) Bioorg Med Chem Lett 29: 2316-2319

• PubMed: 31235263 
• DOI: 10.1016/j.bmcl.2019.06.022
• Primary Citation of Related Structures:  
  6Q2X, 6Q36


• PubMed Abstract: 
  

The YAP-TEAD protein-protein interaction is a potential therapeutic target to treat cancers in which the Hippo signaling pathway is deregulated. However, the extremely large surface of interaction between the two proteins presents a formidable challenge for a small molecule interaction disrupter approach. We have accomplished progress towards showing the feasibility of this approach by the identification of a 15-mer peptide able to potently (nanomolar range) disrupt the YAP-TEAD interaction by targeting only one of the two important sites of interaction. This peptide, incorporating non-natural amino acids selected by structure-based design, is derived from the Ω-loop sequence 85-99 of YAP.

---

Organizational Affiliation: 

Novartis Institutes for BioMedical Research, CH-4002 Basel, Switzerland.

Macromolecules

Entity ID: 1
Molecule	Chains	Sequence Length	Organism	Details	Image
Transcriptional enhancer factor TEF-3	A	220	Homo sapiens	Mutation(s): 0  Gene Names: TEAD4, RTEF1, TCF13L1, TEF3
UniProt & NIH Common Fund Data Resources
Find proteins for Q15561 (Homo sapiens) Explore Q15561  Go to UniProtKB:  Q15561
PHAROS:  Q15561

Entity ID: 2
Molecule	Chains	Sequence Length	Organism	Details	Image
Transcriptional coactivator YAP1	B [auth L]	41	Homo sapiens	Mutation(s): 0  Gene Names: YAP1, YAP65
UniProt & NIH Common Fund Data Resources
Find proteins for P46937 (Homo sapiens) Explore P46937  Go to UniProtKB:  P46937
PHAROS:  P46937

Small Molecules

Ligands 2 Unique
ID	Chains	Name / Formula / InChI Key	2D Diagram
MYR	D [auth A]	MYRISTIC ACID C14 H28 O2 TUNFSRHWOTWDNC-UHFFFAOYSA-N
GOL	C [auth A]	GLYCEROL C3 H8 O3 PEDCQBHIVMGVHV-UHFFFAOYSA-N

Experimental Data & Validation

Experimental Data

• Method: X-RAY DIFFRACTION
• Resolution: 2.10 Å
• R-Value Free: 0.253 
• R-Value Work: 0.232 
• R-Value Observed: 0.233 
• Space Group: P 4₁ 2₁ 2

Unit Cell:

Length ( Å )	Angle ( ˚ )
a = 59.096	α = 90
b = 59.096	β = 90
c = 158.949	γ = 90

Software Package:

Software Name	Purpose
REFMAC	refinement
XDS	data reduction
XSCALE	data scaling
PHASER	phasing
PDB_EXTRACT	data extraction

Structure Validation

Entry History 

Deposition Data

• Released Date: 2019-07-03 
Deposition Author(s): Kallen, J.

Revision History  

• Version 1.0: 2019-07-03
  Type: Initial release
  
• Version 1.1: 2019-08-21
  Changes: Data collection, Database references
• Version 1.2: 2019-10-23
  Changes: Data collection